These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 12508359)
61. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma. Zhang DZ; Wei XD; Wang XP World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473 [TBL] [Abstract][Full Text] [Related]
62. Liver chemoembolization of hepatocellular carcinoma using TANDEM Delicque J; Guiu B; Boulin M; Schwanz H; Piron L; Cassinotto C Future Oncol; 2018 Nov; 14(26):2761-2772. PubMed ID: 29953255 [TBL] [Abstract][Full Text] [Related]
63. Chemoembolization Adopting Polyethylene Glycol Drug-Eluting Embolics Loaded With Doxorubicin for the Treatment of Hepatocellular Carcinoma. Aliberti C; Carandina R; Sarti D; Mulazzani L; Pizzirani E; Guadagni S; Fiorentini G AJR Am J Roentgenol; 2017 Aug; 209(2):430-434. PubMed ID: 28537756 [TBL] [Abstract][Full Text] [Related]
64. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752 [TBL] [Abstract][Full Text] [Related]
65. Oily chemoembolization combined with degradable starch microspheres for HCC with cirrhosis. Murata S; Tajima H; Ichikawa K; Onozawa S; Wang J; Kumita S; Nomura K Hepatogastroenterology; 2008; 55(84):1041-6. PubMed ID: 18705325 [TBL] [Abstract][Full Text] [Related]
66. Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome. Herber S; Biesterfeld S; Franz U; Schneider J; Thies J; Schuchmann M; Düber C; Pitton MB; Otto G Cardiovasc Intervent Radiol; 2008; 31(4):768-77. PubMed ID: 18196335 [TBL] [Abstract][Full Text] [Related]
67. [Effects of transcatheter arterial chemoembolization with pingyangmycin-lipiodol emulsion on VX2 liver tumors in rabbits]. Liu X; Luo XP; Cao WT; Deng H Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):611-6. PubMed ID: 23207156 [TBL] [Abstract][Full Text] [Related]
69. Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization. Kim DY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Shin SW; Choo SW; Do YS; Rhee JC World J Gastroenterol; 2006 Nov; 12(43):6992-7. PubMed ID: 17109521 [TBL] [Abstract][Full Text] [Related]
70. Single-bolus regional chemotherapy with doxorubicin versus chemoembolization in a rabbit VX2 tumor model. Cho SK; Shin SW; Do YS; Jang KT; Choo SW; Park KB; Park HS; Chang IS Diagn Interv Radiol; 2011 Dec; 17(4):374-80. PubMed ID: 21225581 [TBL] [Abstract][Full Text] [Related]
71. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma. Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945 [TBL] [Abstract][Full Text] [Related]
72. Safety and Feasibility of Chemoembolization with Doxorubicin-Loaded Small Calibrated Microspheres in Patients with Hepatocellular Carcinoma: Results of the MIRACLE I Prospective Multicenter Study. Richter G; Radeleff B; Stroszczynski C; Pereira P; Helmberger T; Barakat M; Huppert P Cardiovasc Intervent Radiol; 2018 Apr; 41(4):587-593. PubMed ID: 29167967 [TBL] [Abstract][Full Text] [Related]
73. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma. Kloeckner R; Weinmann A; Prinz F; Pinto dos Santos D; Ruckes C; Dueber C; Pitton MB BMC Cancer; 2015 Jun; 15():465. PubMed ID: 26059447 [TBL] [Abstract][Full Text] [Related]
74. Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE. Wang Z; Chapiro J; Schernthaner R; Duran R; Chen R; Geschwind JF; Lin M Acad Radiol; 2015 Jul; 22(7):840-5. PubMed ID: 25863795 [TBL] [Abstract][Full Text] [Related]
75. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis. Ni JY; Xu LF; Wang WD; Sun HL; Chen YT World J Gastroenterol; 2014 Dec; 20(45):17206-17. PubMed ID: 25493037 [TBL] [Abstract][Full Text] [Related]
76. Combination of radiofrequency ablation with transarterial chemoembolization for treatment of hepatocellular carcinoma: experience from a Danish tertiary liver center. Bharadwaz A; Bak-Fredslund KP; Villadsen GE; Nielsen JE; Simonsen K; Sandahl TD; Grønbæk H; Nielsen DT Acta Radiol; 2016 Jul; 57(7):844-51. PubMed ID: 26342009 [TBL] [Abstract][Full Text] [Related]
77. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma. Bayraktar Y; Balkanci F; Kayhan B; Uzunalimoglu B; Gokoz A; Ozisik Y; Gurakar A; Van Thiel DH; Firat D Hepatogastroenterology; 1996; 43(9):681-7. PubMed ID: 8799415 [TBL] [Abstract][Full Text] [Related]
78. Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy. Miki I; Murata S; Uchiyama F; Yasui D; Ueda T; Sugihara F; Saito H; Yamaguchi H; Murakami R; Kawamoto C; Uchida E; Kumita SI World J Gastroenterol; 2017 Sep; 23(35):6437-6447. PubMed ID: 29085193 [TBL] [Abstract][Full Text] [Related]
79. Assessment of Response to Transcatheter Arterial Chemoembolization with Doxorubicin-eluting Microspheres: Tumor Biology and Hepatocellular Carcinoma Recurrence in a 5-year Transplant Cohort. Sandow TA; Arndt SE; Albar AA; DeVun DA; Kirsch DS; Gimenez JM; Bohorquez HE; Gilbert PJ; Thevenot PT; Nunez KG; Galliano GA; Cohen AJ; Kay D; Gulotta PM Radiology; 2018 Mar; 286(3):1072-1083. PubMed ID: 29206595 [TBL] [Abstract][Full Text] [Related]